Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine
- PMID:21950492
- DOI: 10.1111/j.1600-0412.2011.01285.x
Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine
Abstract
Objective: Analysis of factors influencing surgical intervention rate after home medical termination of pregnancy (TOP) by women in countries without access to safe services using the telemedical service 'Women on Web'.
Design: Cohort study.
Setting: Women with an unwanted pregnancy less than nine weeks pregnant who used the telemedicine service of Women on Web between February 2007 and September 2008 and provided follow-up information.
Sample: Women who used medical TOP with a known follow up.
Methods: Information from the online consultation, follow-up form and emails was used to analyze the outcome of the TOP.
Main outcome measures: Ongoing pregnancy, reason for surgical intervention, perceived complications and satisfaction.
Results: Of the 2 323 women who did the medical TOP and had no ongoing pregnancy, 289 (12.4%) received a surgical intervention. High rates were found in Eastern Europe (14.8%), Latin America (14.4%) and Asia/Oceania (11.0%) and low rates in Western Europe (5.8%), the Middle East (4.7%) and Africa (6.1%; p=0.000). More interventions occurred with longer gestational age (p=0.000). Women without a surgical intervention more frequently reported satisfaction with the treatment (p=0.000).
Conclusions: The large regional differences in the rates of reported surgical interventions after medical TOP provided by telemedicine cannot be explained by demographic factors or differences in gestational length. It is likely that these differences reflect different clinical practice and local guidelines on (incomplete) abortion rather than complications that genuinely needed surgical intervention. Surgical interventions significantly influenced womens' views on the acceptability of the TOP.
© 2011 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2011 Nordic Federation of Societies of Obstetrics and Gynecology.
Similar articles
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K.Kopp Kallner H, et al.Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19.Hum Reprod. 2010.PMID:20172871
- Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.Gomperts RJ, Jelinska K, Davies S, Gemzell-Danielsson K, Kleiverda G.Gomperts RJ, et al.BJOG. 2008 Aug;115(9):1171-5; discussion 1175-8. doi: 10.1111/j.1471-0528.2008.01787.x. Epub 2008 Jul 10.BJOG. 2008.PMID:18637010
- [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].Faucher P, Baunot N, Madelenat P.Faucher P, et al.Gynecol Obstet Fertil. 2005 Apr;33(4):220-7. doi: 10.1016/j.gyobfe.2005.02.021. Epub 2005 Mar 22.Gynecol Obstet Fertil. 2005.PMID:15894206Clinical Trial.French.
- Current medical abortion care.Creinin MD.Creinin MD.Curr Womens Health Rep. 2003 Dec;3(6):461-9.Curr Womens Health Rep. 2003.PMID:14613667Review.
- Expanding medical abortion: can medical abortion be effectively provided without the routine use of ultrasound?Kaneshiro B, Edelman A, Sneeringer RK, Ponce de Leon RG.Kaneshiro B, et al.Contraception. 2011 Mar;83(3):194-201. doi: 10.1016/j.contraception.2010.07.023. Epub 2010 Sep 17.Contraception. 2011.PMID:21310279Review.
Cited by
- Mobile phone-based mHealth approaches for public health surveillance in sub-Saharan Africa: a systematic review.Brinkel J, Krämer A, Krumkamp R, May J, Fobil J.Brinkel J, et al.Int J Environ Res Public Health. 2014 Nov 12;11(11):11559-82. doi: 10.3390/ijerph111111559.Int J Environ Res Public Health. 2014.PMID:25396767Free PMC article.Review.
- The Case for Telemedical Early Medical Abortion in England: Dispelling Adult Safeguarding Concerns.Parsons JA, Romanis EC.Parsons JA, et al.Health Care Anal. 2022 Mar;30(1):73-96. doi: 10.1007/s10728-021-00439-9. Epub 2021 Oct 23.Health Care Anal. 2022.PMID:34687384Free PMC article.
- Medical abortion at 13 or more weeks gestation provided through telemedicine: A retrospective review of services.Kapp N, Andersen K, Griffin R, Handayani AP, Schellekens M, Gomperts R.Kapp N, et al.Contracept X. 2021 Jan 25;3:100057. doi: 10.1016/j.conx.2021.100057. eCollection 2021.Contracept X. 2021.PMID:33615210Free PMC article.
- Telemedicine for medical abortion: a systematic review.Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K.Endler M, et al.BJOG. 2019 Aug;126(9):1094-1102. doi: 10.1111/1471-0528.15684. Epub 2019 Apr 25.BJOG. 2019.PMID:30869829Free PMC article.
- Evidence of global demand for medication abortion information: an analysis of www.medicationabortion.com.Foster AM, Wynn LL, Trussell J.Foster AM, et al.Contraception. 2014 Mar;89(3):174-80. doi: 10.1016/j.contraception.2013.05.005. Epub 2013 May 20.Contraception. 2014.PMID:24360644Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical